News

Quack Nurse Fails To Testify At Inquest

Quack Nurse Fails To Testify At Inquest
  • PublishedMay 17, 2017

A mild drama occurred today at the ongoing Coroner inquest set up by the State Government of Osun to investigate the death of late Sen. Isiaka Adeleke in Osogbo, the State capital, as one Alfred Aderibigbe, the man who was alleged to have administered the deceased with ban substances hours before his demise, requested for 48 hours grace to get himself psychologically fit for his testimony.

A visibly shaken Aderibigbe who was drenched in his sweat, fought hard to dry the tears that flowed down his eyes. For the few minutes he took the stand, he was shaking, frightful and possessed an unstable appearance.

Consequently, his lawyer, Mr Lekan Alabi, presented a motion for adjournment, arguing that the summon for his client to come and testify was delivered to him yesterday. He further averred that his client, Mr. Aderibigbe was psychologically unfit to give his testimony.

Mr. Alabi further pleaded with the court for Aderibigbe’s hearing to be postponed until Friday, 19th May 2017 to allow his client enough time prepare for the testimony in court.

In his ruling, the chairman of Coroner inquest, Olusegun Ayilara, assured Mr. Aderibigbe that it wasn’t criminal proceedings, but a coroner’s inquest to determine what took place.

He further adjourned Aderibigbe’s hearing till Thursday, 18th of May, 2017.

Earlier, Consultant Pathologist at the Ladoke Akintola University of Technology

Teaching Hospital, Osogbo, Dr Femi Taiwo Solaja, had revealed a explained that his autopsy findings showed conclusively that Sen. Adeleke died of aspiration as a result of multiple drug overdose.

Dr. Solaja dismissed claims that the late senator had died of a heart condition, stating that although his heart showed signs of inflation, this was however not responsible for his sudden death.

Solaja said the autopsy showed the deceased was intravenously injected with an overdose of certain powerful drugs including the banned Analgin.

Leave a Reply

Your email address will not be published. Required fields are marked *